A last-mile pediatric medicines platform
Closing the last-mile pediatric medicines gap.
The science is ready — but too many proven therapies never reach children. PediaMed gets them past the system that stalls them.
The five chronic commercialization challenges we fix.
A proven medicine is a promise to a child.
We carry it the last mile.
Where pediatric medicines stall
Last-mile investment — for pediatric medicines that are clinically meaningful and commercially viable, and simply need an owner whose whole strategy is the finish.
Explore Ventures →Last-mile completion — a 501(c)(3) for the medicines the market can't reward, carried by philanthropy to the children who need them.
Visit the Institute →PediaMed focuses where execution fails: the last mile.
However you've come to the table
Back the last mile and the returns that come with finishing it.
Where do I sign → For pharmaHand off a stranded, shelved, or non-strategic asset to a home built for it.
Get it a home → For philanthropyFund a proven medicine across the finish line to a child who's waiting.
Make a gift →
Founder
Director of Commercialization Operations at GSK · Founder of SharePath · Co-founder of Health-Scripts · MBA, Duke University. He built PediaMed to bring commercial discipline to the last mile of pediatric medicine.